XML 35 R23.htm IDEA: XBRL DOCUMENT v3.25.1
SEGMENT REPORTING
 3 Months Ended
Mar. 31, 2025
Segment Reporting [Abstract]  
SEGMENT REPORTING

NOTE 14 – SEGMENT REPORTING

 

Factors used to identify the Company’s reportable segments include the organizational structure of the Company and the financial information available for evaluation by the chief operating decision-maker in making decisions about how to allocate resources and assess performance. The Company’s operating segments have been broken out based on similar economic and other qualitative criteria. The Company operates all reporting segments in one geographical area (the United States).

 

The Company’s CEO is the chief operating decision-maker.

 

The Company classifies its business interests into reportable segments which are:

 

  ● Integra - Licensed wholesaler of brand, generic and non-drug products – B2B sales
     
  ● Scienture – pharmaceutical research company which is engaged in the research and development of branded pharmaceutical products
     
  ● Unallocated - Other – corporate overhead expense and discontinued operations.

 

Three Months Ended March 31, 2025  Integra   Scienture   Unallocated   Total 
Revenues  $10,258   $-   $-   $10,258 
Cost of Sales   9,585    -    -    9,585 
Gross Profit   673    -    -    673 
Net income (loss)   (298,401)   (1,420,095)   (1,345,501)   (3,063,997)
Interest expense   -    77,500    593,284    670,784 
Depreciation   500    -    -    500 
Total Assets as of March 31, 2025  $3,748,249   $99,377,296   $3,232,986   $106,358,530 

 

Geographic information as of and for the three months ended March 31, 2025 is presented below:-

 

SCHEDULE OF GEOGRAPHIC INFORMATION

  

Revenues For The

Three Months

Ended

March 31, 2025

  

Total Assets

as of

March 31, 2025

 
United States  $10,258   $106,358,530 

 

Three Months Ended March 31, 2024  Integra   Scienture   Unallocated   Total 
Revenues  $-   $-   $-   $- 
Cost of Sales   -    -    -    - 
Gross Profit   -    -    -    - 
Net income (loss)   (238,655)   -    21,484,688    21,246,033 
Interest expense   -    -    98,515    98,515 
Depreciation   500    -    -    500 
Total Assets as of December 31, 2024  $3,260,532   $98,072,001   $3,521,272   $104,853,805 

 

Geographic information as of and for the three months ended March 31, 2024 is presented below:-

 

  

Revenues For The

Three Months

Ended

March 31, 2024

  

Total Assets

as of

December 31, 2024

 
United States  $-   $104,853,805